Evaluation of real‐world outcomes associated with use of a prescription digital therapeutic to treat substance use disorders

Author:

Xiong Xiaorui1ORCID,Braun Stephen1ORCID,Stitzer Maxine2,Luderer Hilary1ORCID,Shafai Gigi1,Hare Brendan1ORCID,Stevenson Michael1,Maricich Yuri1ORCID

Affiliation:

1. Medical Affairs, Pear Therapeutics (US) Boston Massachusetts USA

2. Behavioral Pharmacology Research Unit, Friends Research Institute Baltimore Maryland USA

Publisher

Wiley

Subject

Psychiatry and Mental health,Clinical Psychology,Medicine (miscellaneous)

Reference28 articles.

1. Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the united states: results from the 2020 National Survey on Drug Use and Health (HHS Publication No. PEP21‐07‐01‐003 NSDUH Series H‐56). Accessed October 28 2021. https://www.samhsa.gov/data/

2. Technology-based interventions for the treatment and recovery management of substance use disorders: A JSAT special issue

3. MadrasB AhmadNJ WenJ SharfsteinJ the Prevention Treatment and Recovery Working Group of the Action Collaborative on Countering the U.S. Opioid Epidemic. Improving access to evidence‐based medical treatment for opioid use disorder: strategies to address key barriers within the treatment system.https://nam.edu/improving-access-to-evidence-based-medical-treatment-for-opioid-use-disorder-strategies-to-address-key-barriers-within-the-treatment-system/

4. Dropout rates of in‐person psychosocial substance use disorder treatments: a systematic review and meta‐analysis

5. Relapse and Relapse Prevention

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3